[Influence of various neurotropic drugs (L-dopa and alphamethyl-dopa) in Cushing's disease].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D002940:Circadian Rhythm; D003346:Corticotropin-Releasing Hormone; D003480:Cushing Syndrome / Q000188:drug therapy*; D003907:Dexamethasone; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008750:Methyldopa / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D014667:Vasopressins; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D003907:Dexamethasone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone
Influencia de algunas drogas neurotrópicas (L-dopa y alfametil-dopa) en la enfermedad de Cushing